Drug intelligence / Profile preview

sinefungin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Sinefungin is a natural nucleoside analog isolated from Streptomyces species, structurally related to S‑adenosylmethionine and S‑adenosylhomocysteine. It acts as a potent competitive inhibitor of methyltransferases that use S‑adenosylmethionine as a methyl donor, including DNA methyltransferases (DNMTs), RNA methyltransferases (such as mRNA(guanine-N7)-methyltransferase and mRNA(nucleoside‑2′)-methyltransferase), and protein lysine methyltransferases like SET7/9. Through this inhibition, it blocks the transfer of methyl groups to DNA, RNA, or proteins. Biologically, sinefungin exhibits antifungal, antimicrobial, antiviral, and antiparasitic activities; it has shown efficacy against various fungi and protozoan parasites such as Leishmania spp., Trypanosomes, Plasmodium spp., Cryptosporidium parvum (notably in animal models), and can inhibit viral replication by targeting viral mRNA capping enzymes. Its main research applications are in epigenetics (as an inhibitor of histone H3K4 monomethylation) and infectious disease models[1][3][4][5][8].

Other names
sinefunginSinefunginaSinefungineAdenosyl-OrnithineA 9145, RP 32232
02

Targets

m6A writer (m6A writer complex)SETD7 (SET domain containing lysine methyltransferase 7)

Beyond the preview

Go deeper on sinefungin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sinefungin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call